💊Executive Order on Most-Favored-Nation Drug Pricing Impact
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients
Summary
Executive Order 14297 aims to rectify the disparity in pharmaceutical pricing between the U.S. and other developed countries. It emphasizes the need for Americans to access drugs at the most-favored-nation prices and outlines immediate policy actions to address foreign pricing disparities. The order also encourages direct-to-consumer sales at these pricing levels, asserting that U.S. patients should benefit from fair drug pricing relative to global standards.
Agencies
- Executive Office of the President
Business Impact
$$$ - High
This Executive Order mandates that U.S. drug prices align with the most-favored-nation pricing, impacting pharmaceutical companies and potentially leading to lowered prices for consumers. It also sets a framework for regulation and enforcement against price discrimination, indicating a significant business environment shift for pharmaceutical manufacturers.